Mass spectral tissue analysis
The invention generally relates to mass spectral analysis. In certain embodiments, methods of the invention involve analyzing a tissue sample using a mass spectrometry technique, in which the technique utilizes a liquid phase that does not destroy native tissue morphology during analysis. Due to the use of a liquid phase that does not destroy native tissue morphology during analysis, a subsequent staining technique can be performed on the tissue sample and an overlaid image can be produced of a mass spectral image and a staining image.
1. A method for producing an overlaid image of a tissue sample, the method comprising:
receiving mass spectral data of a tissue sample that has been generated by using a desorption electrospray ionization (DESI) technique that comprises directing a liquid phase that does not destroy native tissue morphology from a DESI probe onto the tissue sample to thereby desorb one or more compounds from the tissue sample that are analyzed by a mass spectrometer to produce the mass spectral data of the tissue sample, wherein the liquid phase is at least one selected from the group consisting of: dimethylformamide (DMF); tetrahydrofuran (THF); DMF comprising at least one other component DMF:ethanol (EtOH); DMF:water (H 2 O); DMF:acetonitrile (ACN); methanol (MeOH):chloroform (CHCl 3 ); ACN:CHCl 3 ; and ACN:EtOH;
producing a mass spectral image of the tissue sample based on the mass spectral data;
receiving histochemical data of the tissue sample;
producing an optical image of the tissue sample from the histochemical data; and
overlaying the mass spectral image of the tissue sample with the optical image of the tissue sample to produce an overlaid image.
2. The method according to claim 1 , further comprising determining a distribution of the one or more compounds in the tissue sample based on an analysis of the overlaid image.
3. The method according to claim 1 , wherein the histochemical data is produced by H&E staining.
4. The method according to claim 1 , wherein the one or more compounds comprises one or more lipids.
5. The method according to claim 2 , further comprising determining whether an abnormality exists in the tissue sample based on the distribution of the one or more compounds in the tissue sample.
6. The method according to claim 5 , wherein the abnormality is a cancer.
7. A method for producing an overlaid image of a tissue sample comprising a cancerous section, the method comprising:
receiving mass spectral data of a tissue sample comprising a cancerous section that has been generated by using a desorption electrospray ionization (DESI) technique that comprises directing a liquid phase that does not destroy native tissue morphology from a DESI probe onto the tissue sample to thereby desorb one or more compounds from the tissue sample that are analyzed by a mass spectrometer to produce the mass spectral data of the tissue sample, wherein the liquid phase is at least one selected from the group consisting of: dimethylformamide (DMF); tetrahydrofuran (THF); DMF comprising at least one other component DMF:ethanol (EtOH); DMF:water (H 2 O); DMF:acetonitrile (ACN); methanol (MeOH):chloroform (CHCl 3 ); ACN:CHCl 3 ; and ACN:EtOH;
producing a mass spectral image of the tissue sample comprising the cancerous section based on the mass spectral data;
receiving histochemical data of the tissue sample comprising the cancerous section;
producing an optical image of the tissue sample comprising the cancerous section from the histochemical data; and
overlaying the mass spectral image of the tissue sample comprising the cancerous section with the optical image of the tissue sample comprising the cancerous section to produce an overlaid image.
8. The method according to claim 7 , further comprising identifying the cancerous section within the overlaid image.
9. The method according to claim 7 , wherein the histochemical data is produced by H&E staining.
10. The method according to claim 7 , wherein the one or more compounds comprises one or more lipids.